These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30703542)

  • 1. Fullerene-based delivery systems.
    Kazemzadeh H; Mozafari M
    Drug Discov Today; 2019 Mar; 24(3):898-905. PubMed ID: 30703542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fullerenes For Anticancer Drug Targeting: Teaching An Old Dog A New Trick.
    Dhiman S; Kaur A; Sharma M
    Mini Rev Med Chem; 2022; 22(22):2864-2880. PubMed ID: 35301947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor Activity and Potential Mechanism of Novel Fullerene Derivative Nanoparticles.
    Ye L; Kollie L; Liu X; Guo W; Ying X; Zhu J; Yang S; Yu M
    Molecules; 2021 May; 26(11):. PubMed ID: 34071369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransport kinetics and intratumoral biodistribution of malonodiserinolamide-derivatized [60]fullerene in a murine model of breast adenocarcinoma.
    Lapin NA; Vergara LA; Mackeyev Y; Newton JM; Dilliard SA; Wilson LJ; Curley SA; Serda RE
    Int J Nanomedicine; 2017; 12():8289-8307. PubMed ID: 29180866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does C
    Borowik A; Prylutskyy Y; Kawelski Ł; Kyzyma O; Bulavin L; Ivankov O; Cherepanov V; Wyrzykowski D; Kaźmierkiewicz R; Gołuński G; Woziwodzka A; Evstigneev M; Ritter U; Piosik J
    Colloids Surf B Biointerfaces; 2018 Apr; 164():134-143. PubMed ID: 29413590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fullerene C₆₀ as a multifunctional system for drug and gene delivery.
    Montellano A; Da Ros T; Bianco A; Prato M
    Nanoscale; 2011 Oct; 3(10):4035-41. PubMed ID: 21897967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors or toxins? Large library target-specific screening of fullerene-based nanoparticles for drug design purpose.
    Ahmed L; Rasulev B; Kar S; Krupa P; Mozolewska MA; Leszczynski J
    Nanoscale; 2017 Jul; 9(29):10263-10276. PubMed ID: 28696446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Update Report on the Biosafety and Potential Toxicity of Fullerene-Based Nanomaterials toward Aquatic Animals.
    Malhotra N; Audira G; Castillo AL; Siregar P; Ruallo JMS; Roldan MJ; Chen JR; Lee JS; Ger TR; Hsiao CD
    Oxid Med Cell Longev; 2021; 2021():7995223. PubMed ID: 34336114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance.
    Peng Y; Yang D; Lu W; Hu X; Hong H; Cai T
    Acta Biomater; 2017 Oct; 61():193-203. PubMed ID: 28801268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ab Initio Insight into the Interaction of Metal-Decorated Fluorinated Carbon Fullerenes with Anti-COVID Drugs.
    Katin KP; Kochaev AI; Kaya S; El-Hajjaji F; Maslov MM
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of fullerene-containing complexes via microgel swelling and shear-induced release.
    Tarabukina E; Zoolshoev Z; Melenevskaya E; Budtova T
    Int J Pharm; 2010 Jan; 384(1-2):9-14. PubMed ID: 19766708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fullerene (C60)-based tumor-targeting nanoparticles with "off-on" state for enhanced treatment of cancer.
    Shi J; Wang B; Wang L; Lu T; Fu Y; Zhang H; Zhang Z
    J Control Release; 2016 Aug; 235():245-258. PubMed ID: 27276066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fullerene Doxorubicin Nanotransporter for Target Interaction with mutated gene BRCA2].
    Skaličková S; Löfelmann M; Gargulák M; Dočekalová M; Ruttkay-Nedecký B; Suchý P; Kepinská M; Kizek R
    Klin Onkol; 2017; 30(Supplementum1):177-179. PubMed ID: 28471200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational studies of the binding mechanisms of fullerenes to human serum albumin.
    Li J; Jiang L; Zhu X
    J Mol Model; 2015 Jul; 21(7):177. PubMed ID: 26093686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C60-fullerenes as Drug Delivery Carriers for Anticancer Agents: Promises and Hurdles.
    Kumar M; Raza K
    Pharm Nanotechnol; 2017; 5(3):169-179. PubMed ID: 29361902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fullerene containing polymers: a review on their synthesis and supramolecular behavior in solution.
    Ravi P; Dai S; Wang C; Tam KC
    J Nanosci Nanotechnol; 2007; 7(4-5):1176-96. PubMed ID: 17450886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular localisation of a water-soluble fullerene derivative.
    Foley S; Crowley C; Smaihi M; Bonfils C; Erlanger BF; Seta P; Larroque C
    Biochem Biophys Res Commun; 2002 May; 294(1):116-9. PubMed ID: 12054749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fullerenol nanoparticles: toxicity and antioxidant activity.
    Injac R; Prijatelj M; Strukelj B
    Methods Mol Biol; 2013; 1028():75-100. PubMed ID: 23740114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fullerene-based amino acid ester chlorides self-assembled as spherical nano-vesicles for drug delayed release.
    Lin MS; Chen RT; Yu NY; Sun LC; Liu Y; Cui CH; Xie SY; Huang RB; Zheng LS
    Colloids Surf B Biointerfaces; 2017 Nov; 159():613-619. PubMed ID: 28858664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced brain penetration of hexamethonium in complexes with derivatives of fullerene C60.
    Piotrovskiy LB; Litasova EV; Dumpis MA; Nikolaev DN; Yakovleva EE; Dravolina OA; Bespalov AY
    Dokl Biochem Biophys; 2016 May; 468(1):173-5. PubMed ID: 27417712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.